[针对急性髓性白血病开发新药的未来前景]
1Department of Blood Transfusion, University of Fukui Hospital.
概括
新型药物和免疫疗法在治疗急性髓性白血病 (AML) 中表现有前途,旨在改善缓解和生活质量,尽管当前治疗的复发率高.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 标准的急性髓性白血病 (AML) 治疗方法 (cytarabine 和 anthracycline) 已经使用了几十年.
- 最近在AML细胞遗传学和分子生物学方面的进展导致日本自2018年以来批准了新的药物.
- 尽管有进展,但AML仍然难以治愈,复发的风险很大.
研究的目的:
- 审查日本尚未批准的急性髓性白血病 (AML) 的新兴疗法.
- 讨论用于AML治疗的新药和正在研究的治疗抗体.
- 探索这些新疗法在单疗法和组合疗法中的潜力.
主要方法:
- 对AML最近批准的和正在研究的药物的审查.
- 对新型药物的分析,包括CPX-351,IDH抑制剂,脑膜抑制剂和口服阿扎西提丁.
- 检查治疗性抗体,如双特异性T细胞参与剂 (BiTEs),DART和免疫检查点抑制剂.
主要成果:
- 几种新型药物和治疗抗体正在临床试验或AML的开发中.
- 这些药物正在作为单疗法和与化疗或向药物 (如venetoclax) 结合进行评估.
- 阿扎西蒂丁和维尼托克拉克斯的组合是当前调查中的一个关键疗法.
结论:
- 对于急性髓性白血病 (AML) 治疗,正在出现新的治疗策略.
- 研究中的药物和免疫疗法有可能改善AML的治疗结果.
- 未来的AML治疗包括针对白血病细胞消除,长期缓解和改善生活质量的个性化方法.
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Bone Marrow Sampling and Transplants
324
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
324
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


